Glimrus PG 1mg/500mg/15mg Tablet SR
Marketer
Cagrus Biopharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimrus PG 1mg/500mg/15mg Tablet SR
Combiflex-D 1mg/500mg/15mg extended-release tablets manage blood glucose in adults with type 2 diabetes. This medication, used alongside diet and exercise, enhances insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions; take with food to prevent stomach irritation. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia risk increases with concurrent antidiabetic medications, alcohol consumption, or skipped meals; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before initiating treatment. Kidney function tests are typically performed before treatment begins. Limit alcohol consumption to minimize potential adverse reactions.
Primary Ingredients of Glimrus PG 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Glimrus PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimrus PG 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrus PG 1mg/500mg/15mg Tablet SR whole; do not chew, crush, or fracture it. Administer this extended-release tablet with a meal.
Common Side effects of Glimrus PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimrus PG 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrus PG 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.
How Glimrus PG 1mg/500mg/15mg Tablet SR works:
Glimrus PG 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood sugar management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimrus PG 1mg/500mg/15mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimrus PG 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimrus PG 1mg/500mg/15mg tablet is likely unsuitable for breastfeeding mothers. Preliminary evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimrus PG 1mg/500mg/15mg SR tablets to individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is recommended. Glimrus PG 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimrus PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glimrus PG 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimrus PG 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glimrus PG 1mg/500mg/15mg SR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimrus PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently